Article
Organometallics, Vol. 29, No. 7, 2010 1727
[Rh(COD)Cl]2 and [Rh(dppe)Cl]2;63 the catalyst precursors
[Rh(nbd)(L5)][BArF4],4 [Rh(nbd)(L6)][BArF4],4 [Rh(nbd)(L7)]-
[BArF4],28 [Rh(nbd)(DPEphos)][BArF4],21 and [Rh(nbd)(POP0)]-
[BArF4];36 and the bis-acetone complexes [Rh(L4)(acetone)2]-
[BArF ],4 [Rh(L7)(acetone)2][BArF4],4 [Rh(L6)(acetone)2][BArF ],4
Microanalysis for C78H52BF24OP2Rh (1636.9): calcd C 57.2, H
3.20; obsd C 57.5, H 3.19.
62
[Rh(L)(H)2(acetone)][BArF4] (L = POP0, 8; Xantphos, 12).
The title compounds were prepared in situ by placing a solu-
tion of [Rh(nbd)(L)][BArF4] (6.7 ꢁ 10-6 mol) in d6-acetone
(0.3 mL) under 4 atm of hydrogen (298/77 K = 3.9). These com-
pounds where characterized in situ by NMR spectroscopy and
ESI-MS.
4
4
and [Rh(DPEphos)(acetone)2][BArF
]
4
21 were all prepared by pub-
lished literature methods or variations thereof using Na[BArF4] as
the chloride extracting agent. Aldehyde I was purchased from
Aldrich and distilled before use. All other chemicals are commercial
products and were used as received. Hydroacylation products III
and IV were identified by comparison with previously reported
data.15 Elemental analyses for the new compounds, apart from 3,
were not satisfactorily obtained due to the fact that all crystallized
with small amounts of intractable oil. NMR spectra of all the new
compounds that could be isolated as solids are provided in the
Supporting Information.
[Rh(POP0)(H)2(acetone)][BArF4], 8. 1H NMR (500 MHz, d6-
acetone): δ 8.09-6.96 [m, 32H, Ar-H þ BArF4 {7.79 (8H, BArF4),
7.67 (4H, BArF4)}], 4.27 (br, 4H, O-CH2), 3.18 (br, 4H, P-CH2),
-19.84 (br, fwhm = 106 Hz, 2H, Rh-H) (coordinated d6-acetone
is not observed). 31P{1H} NMR (202 MHz, d6-acetone): δ 48.4 [d,
J(RhP) = 121]. 1H NMR (500 MHz, d6-acetone, 225 K): δ 8.02-
7.38 [m, 32H, Ar-H þ BArF {7.82 (8H, BArF4), 7.73 (4H,
4
BArF4)}], 4.35 (m, 2H, O-CH2), 04.16 (m, 2H, O-CH2 ), 3.42 (m,
0
Crystallography. Data were acquired on a Nonius Kappa
CCD diffractometer using graphite-monochromated Mo KR
2H, P-CH2), 2.94 (m, 2H, P-CH2 ), -19.25 [dtd, J(RhH) = 24.5,
J(PH) = 13.9, J(HH) = 10.7, 1H, Rh-H], -20.27 [dtd, J(RhH) =
24.3, J(PH) = 13.4, J(HH) = 10.7, 1H, Rh-H]. 31P{1H} NMR
(202 MHz, d6-acetone, 225 K): δ 49.0 [d, J(RhP) = 121]. ESI-MS
(acetone, 60 °C, 4.5 kV) positive ion: (minor peak) [M]þ m/z =
605.1 (calcd 605.1); (major peak) [M - acetone]þ m/z = 547.1
(calcd 547.1). ESI-MS (acetone, 60 °C, 4.5 kV) positive ion: m/z,
773.2 (Mþ calcd 773.2).
radiation (λ = 0.71073 A) and a low-temperature device;64 data
˚
were collected using COLLECT; reduction and cell refinement
were performed using DENZO/SCALEPACK.65 Structures
were solved by direct methods using DIRDIF99 (11)66 or
SIR2004 (9, 13, 15)67 and refined with full-matrix least-squares
on F2 using SHELXL-97.68 All non-hydrogen atoms were
refined anisotropically. The hydride ligands (H0a and H0b in
9 and 13, H10 in 11, H0 in 15) were located on the difference map
and freely refined; all other hydrogen atoms were placed in
calculated positions using the riding model. Disorder of the
phosphine ligand in 9 was treated by modeling one of the
substituents over two sites and restraining its geometry; this
included using rigid body restraints. Disorder of the thioether-
acyl ligand in 15 was treated by modeling part of it over two sites
and restraining its geometry. Disorder of the phosphine back-
bone in 15 was treated by modeling the Xantphos methyl groups
over two sites and restraining their geometry. Rotational dis-
order of the anion CF3 groups was treated by modeling the
fluorine atoms or the entire CF3 group over two or three sites
and restraining their geometry. Problematic solvent disorder in
9 and 15 was treated using the SQUEEZE algorithm.68 Re-
straints to thermal parameters were applied where necessary in
order to maintain sensible values. See Table S1 in the Supporting
Information for further crystallographic data.
[Rh(Xantphos)(H)2(acetone)][BArF4], 12. 1H NMR (500 MHz,
d6-acetone): δ 8.34-6.85 [m, 38H, Ar-H þ BArF {7.79 (8H,
4
BArF4), 7.68 (4H, BArF4)}], 2.25-1.54 (br m, 6H, CH3), -18.81 (1
H, br, Rh-H), -19.00 (br, 1H, Rh-H). 31P{1H} NMR (202 MHz,
d6-acetone): δ 45.4 [d, J(RhP) = 121]. 1H NMR (500 MHz, d6-
acetone, 225 K): δ 8.26-7.20 [m, 38H, Ar-H þ BArF4 {7.83 (8H,
BArF4), 7.73 (4H, BArF4)}], 1.94 (s, 3H, CH3), 1.70 (s, 3H, CH3 ),
0
-18.44 [dtd, J(RhH)=22.1, J(PH)=12.8, J(HH)=9.5, 1H, Rh-
H], -19.17 [dtd, J(RhH) = 31.4, J(PH) = 14.5, J(HH) = 9.2, 1H,
Rh-H]. 31P{1H} NMR (202 MHz, d6-acetone, 225 K): δ 46.0 [d,
J(RhP) = 121]. ESI-MS (acetone, 60 °C, 4.5 kV) positive ion:
(minor peak) [M]þ m/z = 741.15 (calcd 741.15); (major peak)
[M - acetone]þ m/z = 683.11 (calcd 683.10).
[Rh(L)(H)2(NCMe)][BArF4] (L = POP0, 9, Xantphos, 13).
[Rh(L)(nbd)][BArF4] (1.5 ꢁ 10-2 mmol) in d6-acetone (0.3 mL)
was freeze-thaw-degassed and backfilled with hydrogen at
77 K. The solution was shaken for 30 min at room temperature.
The solution was then freeze-thaw-degassed again and back-
filled with argon at room temperature. Acetonitrile (7.8 μL,
1.5 ꢁ 10-1 mmol, 10 equiv) was added and the solution shaken
for 30 min. The solution was transferred into a Young’s crystal-
lization tube. Solvent was removed in vacuo and the resulting
residue washed with pentane (3 ꢁ 2 mL), then recrystallized by
diffusion of hexane into a fluorobenzene solution of the crude
product to yield colorless crystals. Yield: 43%, 9.3 mg and 73%,
17.4 mg, respectively.
Synthesis of Complexes. [Rh(Xantphos)(nbd)][BArF4], 3.
Xantphos (125.5 mg, 2.17 ꢁ 10-4 mol, 2 equiv) in CH2Cl2 (13
mL) was added dropwise over 30 min to [Rh(nbd)Cl]2 (50 mg,
1.08 ꢁ 10-4 mol, 1 equiv) in CH2Cl2 (1 mL). The resulting
reaction mixture was then added dropwise to Na[BArF4] (192.2
mg, 2.17 ꢁ 10-4 mol, 2 equiv) in CH2Cl2 (1 mL), and the mixture
was stirred for 2 h. The solution was filtered, and the filtrate was
reduced to ∼5 mL. Pentane was added to the filtrate until a
precipitate was observed, then layered with pentane (15 mL).
The solution was stored overnight at -18 °C to give orange
crystals, yield = 53%, 189 mg. 1H NMR (300 MHz d6-acetone):
δ 7.79 (m, 8H, BArF4), 7.68 (s, 4H, BArF4), 7.46-6.82 (m, 26H,
Ar), 3.78 (s, 4H, nbd CHdCH), 3.52 (s, 2H, nbd CH), 1.70
(s, 6H,CH3), 1.16 (s, 2H, nbd CH2). 31P NMR (122 MHz
d6-acetone): δ 9.74 [d, J(RhP) = 142]. ESI-MS (acetone,
60 °C, 4.5 kV) positive ion: [M]þ m/z, 773.2 (Mþ calcd 773.2).
[Rh(POP0)(H)2(NCMe)][BArF4], 9. 1H NMR (500 MHz,
CD2Cl2): δ 7.85-7.30 [m, 32 H, Ar-H þ BArF {7.72 (8H,
4
BArF4)0, 7.56 (4H, BArF4)}], 4.10 (m, 2H, O-CH2), 3.53 (m, 2H,
O-CH2 ), 2.92 (m, 4H, P-CH2), -16.69 [dtd, J(RhH) = 21.3,
J(PH)=12.3, J(HH)=8.9, 1H, Rh-H], -19.39 [dtd, J(RhH) =
21.9, J(PH) = 13.1, J(HH) = 8.8, 1H, Rh-H]. 31P{1H} NMR
(202 MHz, CD2Cl2): δ 47.1 [d, J(RhP) = 120 Hz]. ESI-MS
(fluorobenzene, 60 °C, 4.5 kV) positive ion: (minor peak) [M]þ
m/z = 588.0922 (calcd 588.1087); (major peak) [M - MeCN]þ
m/z = 547.0705 (calcd 547.0821).
(62) Giordano, G.; Crabtree, R. H. Inorg. Synth. 1990, 28, 88.
(63) Uehara, A.; Bailar, J. C. J. Organomet. Chem. 1982, 239, 11–15.
(64) Cosier, J.; Glazer, A. M. J. Appl. Crystallogr. 1986, 19, 105–107.
(65) Otwinowski, Z.; Minor, W. In Macromolecular Crystallography,
Part A; Carter, C. W., Sweat, R. M., Eds.; Academic Press: New York, 1997;
Vol. 276.
(66) Beurskens, P. T.; Beurskens, G.; de Gelder, R.; Garcia-Granda,
S.; Gould, R. O.; Israel, R.; Smits, J. M. M. The DIRDIF-99 program
system; University of Nijmegen: Netherlands, 1999.
[Rh(Xantphos)(H)2(NCMe)][BArF4], 13. 1H NMR (500 MHz,
CD2Cl2): δ 7.92-7.29 [m, 38H, Ar-H þ BArF4 {7.72 (8H, BArF4),
7.55 (4H, BArF4)}], 1.91 (s, 3H, CH3), 1.51 (s, 3H, CH3 ), 1.16 (s,
0
3H, coordinated MeCN CH3), -15.36 [dtd, J(RhH) =20.3,
J(PH)=12.3, J(HH)=7.8, 1H, Rh-H], -19.36 [dtd, J(RhH) =
30.8, J(PH) = 13.9, J(HH) = 7.8, 1H, Rh-H]. 31P{1H} NMR (202
MHz, CD2Cl2): δ 44.8 [d, J(RhP) = 117 Hz]. ESI-MS (fluoro-
benzene, 60 °C, 4.5 kV) positive ion: (minor peak) [M]þ m/z =
724.0896 (calcd 724.1400); (major peak) [M - MeCN]þ m/z =
683.0745 (calcd 683.1134).
(67) Burla, M. C.; Caliandro, R.; Camalli, M.; Carrozzini, B.;
Cascarano, G. L.; De Caro, L.; Giacovazzo, C.; Polidori, G.; Spagna,
R. J. Appl. Crystallogr. 2005, 38, 381–388.
(68) Spek, A. L. J. Appl. Crystallogr. 2003, 36, 7–13.